Chris Strazzulla

Associate Director, Business Development @Nda Group - An Ssi Strategy Company

Camden, ME, US

NDA Group is a world leading regulatory, drug development and medical device consultancy. We have a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board many of whom are ex- European Agency and FDA staff. Responsible for developing relationships with pharmaceutical and biotech companies to drive business for our regulatory affairs consultants in the US and Europe. Monthly management of large key account and developing support strategies against assigned territory targets and goals. Collaborates across teams to ensure resources are tailored to meet client expectations and critical filing/submission dates. Target market is Boston Massachusetts and West Coast biotech hubs of San Francisco and San Diego. Our goal is to streamline drug development to accelerate our client’s path to product approval. We support life science companies all over the world and across all phases of development, from pre-clinical to post marketing, to the needs and requirements of regulators and payers alike. We work together with our clients to address key strategic regulatory & reimbursement challenges. Our scientific expertise covers all major therapeutic areas. We have offices in Boston, Princeton, San Francisco, London, Munich, Paris, Stockholm and Zurich NDA supported more than 40% of the new medicinal products that were approved in the EU over the last 5 years.

University of Tampa

Bachelor of Science (BS), Marketing